HCA Healthcare (HCA-N)
NYSE:HCA
347.97
4.93
(1.44%) 1d
Financials
Technical Analysis
Related posts
Nervous markets await Nvidia
This summary was created by AI, based on 4 opinions in the last 12 months.
HCA Healthcare (HCA-N) has recently received mixed reviews from experts, reflecting its recent performance and future potential. After reaching a new all-time high, the company experienced a significant decline in stock value following a disappointing earnings report attributed to external factors such as hurricanes, which impacted revenues. Despite the 13% drop over the past week, some analysts view this as a buying opportunity, emphasizing that the earnings miss was not catastrophic. HCA has a robust presence in the healthcare sector, holding a substantial market share and effectively navigating the pandemic. The company's ongoing efforts in share buybacks and debt reduction demonstrate its commitment to enhancing shareholder value while maintaining a reasonable earnings multiple and supportive management outlook for the full year.
He's been recommending this post-Covid, because it's been benefitting from the huge bounce back in medical procedures that were delayed. HCA just made a new all-time high. But last Friday it reported a shocking top and bottom line miss. Is down 13% in the past week, but this is an opportunity. HCA missed only slightly, not the end of the world. Hurricanes hit revenues by $200-300 million and 60-90 cents per share, a one-off impact. HCA reaffirmed its full-year forecast, though
HCA is one of the largest hospital operators in the US, holding 28% of the market share. It managed the pandemic turmoil better than any other operator. Given the enormous capital requirements there is a high barrier to entry in the space. It trades at 18x earnings and management has been aggressively buying back shares and retiring debt. We recommend setting a stop-loss at $337, looking to achieve $465 -- upside potential of 18%. Yield 0.6%
(Analysts’ price target is $395.00)(A Top Pick Aug 13/15. Down 11.51%.) This has been dead quiet over the course of the last year. It had a lift through November-February, and then basically has consolidated ever since. The group is actually starting to look quite interesting. The sector has been improving from a relative strength standpoint, since June. This could still be a Buy at these levels.
HCA Healthcare(HCA-N) Rating
Ranking : 4 out of 5
Bullish - Buy Signals / Votes : 3
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 3
HCA Healthcare(HCA-N) Frequently Asked Questions
What is HCA Healthcare stock symbol?
HCA Healthcare is a American stock, trading under the symbol HCA-N on the New York Stock Exchange (HCA). It is usually referred to as NYSE:HCA or HCA-N
Is HCA Healthcare a buy or a sell?
In the last year, 3 stock analysts published opinions about HCA-N. 3 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for HCA Healthcare.
Is HCA Healthcare a good investment or a top pick?
HCA Healthcare was recommended as a Top Pick by on . Read the latest stock experts ratings for HCA Healthcare.
Why is HCA Healthcare stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is HCA Healthcare worth watching?
3 stock analysts on Stockchase covered HCA Healthcare In the last year. It is a trending stock that is worth watching.
What is HCA Healthcare stock price?
On 2025-05-02, HCA Healthcare (HCA-N) stock closed at a price of $347.97.
Our PAST TOP PICK with HCA has triggered its stop at $373. To remain disciplined, we recommend covering the position at this time.